Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Calypte Biomedical
AddedFeb 20, 2024
UpdatedJun 18, 2026
Calypte Biomedical

Calypte Biomedical

Public

Calypte Biomedical pioneers in developing innovative HIV diagnostic tests, including FDA-approved urine-based and rapid oral fluid tests.

HQ
Portland, OR, US
Founded
1988
Overview
Compare
Employees

Calypte Biomedical Corporation develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection, sexually transmitted diseases and other chronic diseases.Aware™ HIV-1/2 OMT is such type of product.Our innovative product line includes both point-of-care rapid tests and traditional EIA diagnostic tests.

Calypte is a pioneer in non-blood-based HIV antibody testing. We’re the first and only company to earn approval from the U.S. Food and Drug Administration for a urine-based HIV-1 antibody-screening test and supplemental Western blot.Today, our Aware™ family of rapid oral fluid HIV tests offers unrivalled HIV 1/2 testing flexibility in a non-laboratory setting.

Calypte Biomedical - Similar Companies

Bluejay Diagnostics logo

Bluejay Diagnostics

bluejaydx.com

OraSure Technologies logo

OraSure Technologies

orasure.com

American Bio Medica logo

American Bio Medica

Talis Biomedical logo

Talis Biomedical

talisbio.com

Camtech Diagnostics logo

Camtech Diagnostics

Biomirror Diagnostics logo

Biomirror Diagnostics

TB Biosciences logo

TB Biosciences

Eclipse Diagnostics logo

Eclipse Diagnostics

CareDx logo

CareDx

caredx.com

Aldatu Biosciences logo

Aldatu Biosciences

aldatubio.com

General Fluidics logo

General Fluidics

NAT Diagnostics logo

NAT Diagnostics

Test Diagnostics logo

Test Diagnostics

TAI Diagnostics logo

TAI Diagnostics

YourBio Health logo

YourBio Health

yourbiohealth.com

Calypte Biomedical - Quick Facts

Who are Calypte Biomedical's competitors?

Companies similar to Calypte Biomedical include Bluejay Diagnostics, OraSure Technologies, American Bio Medica and Talis Biomedical.

When was Calypte Biomedical founded?

Calypte Biomedical was founded in 1988.

Where is Calypte Biomedical's headquarters located?

Calypte Biomedical's headquarters is located in Portland, OR, US.

How many employees does Calypte Biomedical have?

Calypte Biomedical has 9 employees as of Feb 5, 2024.

Calypte Biomedical - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Diagnostic Tests
  • HIV Tests
Tags
  • Healthtech
NAICS
  • 334500Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334510Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • 334516Analytical Laboratory Instrument Manufacturing
  • 330000Manufacturing
  • 334000Computer and Electronic Product Manufacturing
SIC
  • 3820Laboratory Apparatus And Analytical, Optical, Measuring, And Control
  • 3826Laboratory Analytical Instruments
ISIC
  • 2651Manufacture of measuring, testing, navigating and control equipment
Show 12 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621100Offices of Physicians
  • 621110Offices of Physicians
  • 621111Offices of Physicians (except Mental Health Specialists)
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 8620Medical and dental practice activities